www.newsday.com | January 26, 2018

Applied DNA Sciences, a Stony Brook biotech company, has entered into a $1 million contract with TheraCann International Benchmark, a cannabis consultancy based in Canada, with plans to break into the marijuana industry using blockchain technology.